Ojas Shah, MD
Otolaryngology · Glen Ellyn, ILNPI 1912196734
Payments from drug & device makers
What this record shows
This record is dominated by education: $5,850 of the $7,317 with a category attached, or 80.0%. Coloplast accounts for 80.0% of it on its own, with 10 other manufacturers making up the rest. Reporting peaked in 2019 at $6,218 and has fallen 96.3% since, to $231 in 2025.
Across 19 payments — averaging $385.08 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Coloplast$6K
- Intersect ENT, Inc.$389
- Acclarent, Inc$292
- GSK$222
- Medtronic$146
- Optinose US, Inc.$115
- plus $303 from 5 others
What the payments were for
- Food & beverage$1,46720%
- Education$5,85080%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Coloplast | 1 | $5,850 |
| Intersect ENT, Inc. | 5 | $389 |
| Acclarent, Inc | 3 | $292 |
| GSK | 2 | $222 |
| Medtronic | 1 | $146 |
| Optinose US, Inc. | 1 | $115 |
| Cochlear Americas | 1 | $94 |
| Neurent Medical Limited | 1 | $84 |
| Stryker | 2 | $69 |
| Integra Lifesciences Corporation | 1 | $33 |
| Hologic Sales And Service, LLC | 1 | $23 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- TITAN$5,850
- PROPEL$292
- NUCALA$222
- TruDi Nav Cable$119
- Acclarent Navwire$116
- Xhance$115
- SINUVA$114
How this compares
$7,317 in reported general payments places this provider in the 85th percentile of 390 otolaryngology providers in Illinois.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ipratropium Bromide | 229 | $5,134 |
| Fluticasone Propionate | 281 | $3,778 |
| Famotidine | 204 | $2,447 |
| Ofloxacin | 34 | $1,278 |
| Azelastine Hcl | 84 | $1,236 |
| Neomycin-Polymyxin-HydrocortNeomycin/Polymyxin B/Hydrocort | 19 | $955 |
| CefuroximeCefuroxime Axetil | 36 | $636 |
| Fluocinolone Acetonide Oil | 21 | $609 |
| Omeprazole | 33 | $447 |
| Gabapentin | 24 | $292 |
| Mupirocin | 45 | $288 |
| Levofloxacin | 27 | $145 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 12 | $87 |
| Methylprednisolone | 20 | $83 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 11 | $69 |
Paid to pharmacies, not to this prescriber.
Other otolaryngology in Glen Ellyn
- David ConleyChicago$630K
- Jayant PintoChicago$628K
- Robert KernChicago$610K
- Robert NaclerioBurr Ridge$229K
- Michael HutzOak Park$103K
- Charles WeingartenGlenview$96K
- Victoria LeeChicago$86K
- Louis PortugalChicago$68K
- Dean ToriumiChicago$63K
- Monica PatadiaChicago$56K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.